Glucose-6-phosphatase is an enzyme that performs the final step in releasing glucose into your bloodstream. It strips a phosphate group from glucose-6-phosphate, producing free glucose that can leave the liver and travel to the rest of your body. Without this enzyme, your liver can make all the glucose it wants, but it can’t actually export it to where it’s needed.
The Reaction It Performs
Every glucose molecule your liver produces, whether from stored glycogen or built from scratch, passes through the same bottleneck: it exists as glucose-6-phosphate, a form of glucose with a phosphate group attached. That phosphate group acts like a lock, trapping glucose inside the cell. Glucose-6-phosphatase removes the phosphate, converting glucose-6-phosphate into free glucose and inorganic phosphate. Only free glucose can cross cell membranes and enter the bloodstream.
This makes glucose-6-phosphatase the gatekeeper of two major metabolic pathways. Glycogenolysis (breaking down stored glycogen) and gluconeogenesis (building new glucose from non-sugar sources like amino acids and lactate) both end at the same point: glucose-6-phosphate sitting in the liver, waiting for this enzyme to set it free.
Where It Lives in the Body
The enzyme sits inside the endoplasmic reticulum, a membrane-bound compartment within cells. Its active site faces the interior of that compartment, not the open cytoplasm. This means glucose-6-phosphate can’t simply bump into the enzyme. A dedicated transporter protein called G6PT shuttles glucose-6-phosphate from the cytoplasm into the endoplasmic reticulum, where the enzyme can act on it. Separate transporters then move the resulting free glucose and phosphate back out. It’s essentially a three-step relay system: transport in, split the molecule, transport out.
The liver is the primary home of glucose-6-phosphatase, which makes sense given the liver’s central role in supplying glucose to the rest of the body. But the enzyme also exists in the kidneys and the lining of the small intestine. The kidneys become especially important during prolonged fasting or in diabetes, contributing up to 25% of the body’s total glucose output under those conditions. The intestine can also pitch in during fasting and after protein-rich meals.
How It Keeps Blood Sugar Stable
Between meals and overnight, your body relies on glucose-6-phosphatase to maintain blood sugar levels. In the first several hours after eating, the liver breaks down glycogen into glucose-6-phosphate, and the enzyme converts it to free glucose for export. As fasting extends beyond 12 to 24 hours and glycogen stores run low, gluconeogenesis takes over, but the final step remains the same: glucose-6-phosphatase releases the finished product.
The body actively ramps up production of this enzyme during longer fasts. In animal studies, liver enzyme levels increased significantly after 48 and 72 hours of fasting, ensuring the liver can keep pace with rising demand for glucose output. The kidneys also boost their enzyme activity during extended fasting, reflecting their growing role as a glucose source.
How Insulin and Glucagon Control It
Your body tightly regulates how much glucose-6-phosphatase your liver makes, and the two main hormones involved work in opposite directions.
Glucagon, released when blood sugar drops, turns up production of the enzyme. It does this through signaling pathways that activate specific proteins in the nucleus, promoting the gene that codes for glucose-6-phosphatase. The result: more enzyme, more glucose released into the blood.
Insulin does the opposite. After a meal, rising insulin levels suppress the gene through multiple overlapping mechanisms. Insulin essentially locks key activator proteins out of the nucleus or disables the helper molecules they need to switch the gene on. This redundancy matters. By shutting down glucose-6-phosphatase production from several angles at once, insulin ensures the liver stops dumping glucose into the blood when there’s already plenty circulating from a meal.
In type 2 diabetes, insulin’s ability to suppress this enzyme weakens. The liver keeps producing glucose-6-phosphatase and exporting glucose even when blood sugar is already high, which is one reason fasting blood sugar levels stay elevated.
What Happens When the Enzyme Is Missing
People born without functional glucose-6-phosphatase have glycogen storage disease type I (also called von Gierke disease). The core problem is straightforward: the liver can make glucose-6-phosphate but can’t convert it to free glucose. So glucose gets trapped, glycogen accumulates in the liver, and blood sugar drops dangerously low between feedings.
Symptoms typically appear around 3 to 4 months of age, when babies begin sleeping through the night and go longer between meals. Low blood sugar can cause seizures. Because glucose-6-phosphate has nowhere to go, it gets diverted into alternative pathways, creating a cascade of metabolic problems: lactic acid builds up in the blood, uric acid levels rise, and blood fats become abnormally elevated.
As children with this condition grow, they often develop an enlarged liver (sometimes giving the abdomen a noticeably swollen appearance), thin limbs, and short stature. Kidney enlargement is common. Later in life, complications can include osteoporosis, gout from high uric acid, kidney disease, and the development of liver tumors called adenomas. These tumors are usually benign but carry a small risk of becoming cancerous.
There are two subtypes. Type Ia involves mutations in the gene for the enzyme itself. Type Ib involves mutations in the transporter that delivers glucose-6-phosphate to the enzyme. People with type Ib face the same metabolic problems plus a shortage of white blood cells, making them vulnerable to recurrent infections and inflammatory bowel disease.
How It’s Diagnosed
Diagnosis starts with the clinical picture and blood work showing the characteristic combination of low blood sugar, high lactate, high uric acid, and elevated blood fats. Genetic testing of the relevant genes is now the first-choice diagnostic method. In cases where genetic results are inconclusive, a liver biopsy can measure enzyme activity directly. Normal activity is about 3.5 micromoles per minute per gram of tissue. In most people with type Ia, activity falls below 10% of that normal level, though rare milder cases show partially reduced activity.